entertainment -WSS

entertainment

author：fashion 2025-08-25 07:28:20 - browse：7942

Jennifer Doudna Feng Zhang CRISPR — CRISPR pioneers Jennifer Doudna and Feng Zhang Illustration: STAT; Photos: AP, Getty

The revolution started in silence.

Jennifer Doudna and Emmanuelle Charpentier, now Nobelists, published their first paper announcing a new enzyme for editing DNA in Science in June 2012. It was called CRISPR-Cas9. It wasn’t until January 2013 that the first paper showing the enzyme would work in cells, from Feng Zhang, was published, also in Science. A similar paper from George Church came out at the same time.

No major media outlet covered the papers. The first story on CRISPR was published that March. But within the ivory tower of academia, it was clear something big was building, as requests for the technology poured in from other researchers and Zhang set up an assembly line in his laboratory to distribute it, with students carrying carefully packed samples to a FedEx office down the street.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Poor hospice wound care hurts patients and families

hotspot

WSS

Morphosys mixed study results for blood cancer drug

Poor hospice wound care hurts patients and families

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

In search for therapies for solid tumors, companies turn to claudin

Congress must reauthorize a committee to support older Americans

Why getting cancer drugs just got harder for rural patients

entertainment

entertainment

knowledge

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Poor hospice wound care hurts patients and families

Anesthesiologist group: stop taking Ozempic before surgery

Flu vaccine offering decent levels of protection this winter, new data show

In Memoriam: Notable people who died in 2023

Scientists unlock the key to scar

Sports medicine is finally prioritizing gender equality

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Tori Bowie and the unacceptable rates of Black maternal death

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

leisure time

Flu vaccine offering decent levels of protection this winter, new data show

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Anthos stroke drug appears safer than common blood thinner

How to fix the rural physician shortage in the U.S.

Medical device lobby: We're tired of waiting on Medicare coverage

hotspot

hotspot

focus

hotspot